Can you explain microcytic hypochromic anemia, including its causes, diagnostic workup, and treatment?

Microcytic Hypochromic Anemia Explained

Microcytic hypochromic anemia is characterized by small red blood cells (MCV <80 fL) with reduced hemoglobin content, most commonly caused by iron deficiency, but requires systematic evaluation to exclude thalassemias, genetic iron metabolism disorders, and sideroblastic anemias before initiating treatment 1.

Definition and Basic Pathophysiology

Microcytic hypochromic anemia results from defective hemoglobin synthesis in erythroid precursors, causing reduced red blood cell volume and decreased hemoglobin concentration 2. The underlying defect can involve:

• Iron availability or metabolism (most common)
• Globin chain synthesis (thalassemias, hemoglobinopathies)
• Heme synthesis (sideroblastic anemias)

Common Causes

Acquired Causes (Most Frequent)

• Iron deficiency anemia (IDA): The most common cause worldwide, affecting 1-4% of men and 4-17% of women in the U.S. 3
• Anemia of chronic disease: Particularly severe cases
• Lead toxicity
• Helicobacter pylori infection, celiac disease, atrophic gastritis (causing malabsorption) 1, 3

Genetic Causes

• Thalassemias: α-thalassemia and β-thalassemia trait 1
• Iron-Refractory Iron Deficiency Anemia (IRIDA): Due to TMPRSS6 mutations 1
• Sideroblastic anemias: Including X-linked sideroblastic anemia (XLSA) from ALAS2 defects, and autosomal recessive forms from SLC25A38 defects 1
• Hypotransferrinemia: From TF gene defects
• Aceruloplasminemia: From ceruloplasmin defects

Diagnostic Workup Algorithm

Step 1: Initial Laboratory Assessment

Measure serum ferritin first 4:

• Ferritin <45 μg/L: Suggests iron deficiency 3
• Ferritin 45-100 μg/L with inflammation: May still indicate iron deficiency; confirm with transferrin saturation, soluble transferrin receptor, or reticulocyte hemoglobin 3
• Ferritin normal/high: Proceed to evaluate for genetic causes

Step 2: Iron Studies Panel

• Serum iron
• Total iron-binding capacity (TIBC)
• Transferrin saturation (TSAT)

Interpretation patterns 1:

• IDA: Low ferritin, low iron, high TIBC, low TSAT
• Anemia of chronic disease: Low iron, low/normal TIBC, low TSAT, normal/high ferritin 4
• IRIDA: Very low TSAT, low-normal ferritin (20-45 μg/L), fails oral iron therapy 1
• Sideroblastic anemia: High ferritin, high TSAT, high iron 1

Step 3: Additional Testing Based on Iron Studies

If ferritin low (IDA suspected):

• Identify source of blood loss (GI evaluation for occult bleeding, menstrual history)
• Screen for malabsorption: H. pylori, celiac serology, atrophic gastritis 3
• Consider GI malignancy in adults with unexplained IDA 4

If ferritin normal/high or oral iron-refractory:

• Hemoglobin electrophoresis: Elevated HbA2 >3.5% diagnostic for β-thalassemia trait 4, 5
• Complete blood count indices:
  • Mentzer index (MCV/RBC): <13 suggests thalassemia, >13 suggests IDA 6
  • RBC count: Elevated in thalassemia, low in IDA 6
• Genetic testing: For α-thalassemia deletions, TMPRSS6 mutations (IRIDA), ALAS2, SLC25A38, ABCB7 1
• Bone marrow examination with Perls staining: If sideroblastic anemia suspected (identifies ring sideroblasts) 1, 7

Step 4: Specialized Testing for Rare Genetic Disorders

Look for clinical clues 1:

• Photosensitivity: Consider congenital erythropoietic porphyria (CEP)
• Isolated ataxia: XLSA with ataxia (ABCB7 defects) 1
• Neurological disease: Multiple genetic causes
• Family history: Autosomal recessive or X-linked patterns

Specific biochemical markers:

• Zinc protoporphyrin (ZnPP): Elevated in iron deficiency and lead toxicity
• Free protoporphyrin (FPP): Accumulates in specific porphyrias
• Ceruloplasmin: Very low/undetectable in aceruloplasminemia 1

Treatment Approach

Iron Deficiency Anemia

Oral iron is first-line 3:

• Ferrous sulfate, ferrous fumarate, or ferrous gluconate: 100 mg elemental iron twice daily on empty stomach 5
• Take with vitamin C (500 mg) to enhance absorption 3
• If intolerant: Try with meals (reduces absorption but improves tolerance) or alternative formulations like ferrous bisglycinate

Intravenous iron indications 3:

• Severe iron deficiency
• Oral iron intolerance or failure
• Malabsorption conditions (celiac disease, inflammatory bowel disease)
• Ongoing blood losses exceeding oral absorption capacity

In celiac disease: Ensure gluten-free diet adherence before declaring oral iron failure 3

Iron-Refractory Iron Deficiency Anemia (IRIDA)

• Oral iron typically ineffective due to severe TMPRSS6 defects 1
• Intravenous iron (iron sucrose or iron gluconate): Improves Hb and ferritin, though complete normalization rarely achieved 1
• Diagnosis requires homozygous or compound heterozygous TMPRSS6 mutations 1

Sideroblastic Anemias

X-linked sideroblastic anemia (XLSA - ALAS2 defects) 1:

• Pyridoxine (vitamin B6) 50-200 mg/day initially: Effective in responsive patients
• Maintenance dose 10-100 mg/day lifelong (avoid neurotoxicity from excessive doses)
• Iron overload management: Phlebotomy if anemia mild; chelation if transfusion-dependent
• Critical: Normalize iron stores before declaring pyridoxine-refractory, as iron overload impairs heme synthesis

Autosomal recessive sideroblastic anemia (SLC25A38 defects) 1:

• Transfusion-dependent: Severe presentation in childhood
• Iron chelation: Mandatory due to transfusional iron overload
• Hematopoietic stem cell transplantation: Only curative option

XLSA with ataxia (ABCB7 defects) 1:

• Mild anemia with cerebellar ataxia
• Supportive management

Critical Pitfalls to Avoid

1. Assuming all microcytic anemia is iron deficiency: Always measure ferritin first 4. Treating thalassemia or sideroblastic anemia with iron causes harmful iron overload 1.

2. Missing coexistent conditions: 7% of children with microcytic anemia have both thalassemia trait and IDA 6. Iron deficiency can mask thalassemia diagnosis.

3. Overlooking malabsorption causes: Test for H. pylori, celiac disease, and atrophic gastritis in oral iron-refractory cases 1, 3.

4. Misinterpreting ferritin in inflammation: Ferritin 45-100 μg/L with inflammatory conditions may still represent iron deficiency; use additional markers 3.

5. Failing to investigate iron-refractory anemia: If no response to adequate oral iron therapy, reassess diagnosis with bone marrow examination and genetic testing 7.

6. Delaying genetic testing in children: Early diagnosis of thalassemia trait is essential for genetic counseling 8, 6.

7. Not screening for GI malignancy: Iron deficiency in adults warrants GI evaluation to exclude cancer 4.